DDR

Isoform-selective Products

DDR Products

  • All (6)
  • DDR Inhibitors (5)
  • New DDR Products
Catalog No. Product Name Information Product Use Citations Product Validations
S7498 DDR1-IN-1 DDR1-IN-1 is a potent and selective discoidin domain receptor 1 (DDR1) receptor tyrosine kinase inhibitor with IC50 of 105 nM, about 3-fold selectivity over DDR2.
Cell Genom, 2024, 4(2):100487
Biomater Sci, 2022, 10.1039/d2bm00543c
EMBO Mol Med, 2021, e11814
S7014 Merestinib (LY2801653) Merestinib (LY2801653) is a type-II ATP competitive, slow-off inhibitor of Met (c-Met) tyrosine kinase with a dissociation constant (Ki) of 2 nM, a pharmacodynamic residence time (Koff) of 0.00132 min(-1) and t1/2 of 525 min. Merestinib (LY2801653) also inhibits MST1R, AXL, ROS1, MKNK1/2, FLT3, MERTK, DDR1 and DDR2 with IC50 of 11 nM, 2 nM, 23 nM, 7 nM, 7 nM, 10 nM, 0.1 nM and 7 nM, respectively.
NPJ Breast Cancer, 2024, 10(1):65
Cancers (Basel), 2024, 16(12)2253
J Clin Invest, 2021, 131(11)146987
F0725New DDR1 Rabbit mAb DDR1,NEP
E1825New 7rh 7rh (DDR1-IN-2) is a potent inhibitor of discoidin domain receptor 1 (DDR1) with an IC50 of 13.1 nM. It also inhibits DDR2 less effectively with an IC50 of 203 nM. It also exhibits antitumor effects in nasopharyngeal carcinoma cells.
E0621 FGFR1/DDR2 inhibitor 1 FGFR1/DDR2 inhibitor 1 is an inhibitor of fibroblast growth factor receptor 1 (FGFR1) and discoidin domain receptor 2 (DDR2).
S6817 VU6015929 VU6015929 is a selective Discoidin Domain Receptor 1/2 (DDR1/2) inhibitor with IC50 of 4.67 nM and 7.39 nM for DDR1 and DDR2, respectively. VU6015929 potently inhibits collagen-IV production.
S7498 DDR1-IN-1 DDR1-IN-1 is a potent and selective discoidin domain receptor 1 (DDR1) receptor tyrosine kinase inhibitor with IC50 of 105 nM, about 3-fold selectivity over DDR2.
Cell Genom, 2024, 4(2):100487
Biomater Sci, 2022, 10.1039/d2bm00543c
EMBO Mol Med, 2021, e11814
S7014 Merestinib (LY2801653) Merestinib (LY2801653) is a type-II ATP competitive, slow-off inhibitor of Met (c-Met) tyrosine kinase with a dissociation constant (Ki) of 2 nM, a pharmacodynamic residence time (Koff) of 0.00132 min(-1) and t1/2 of 525 min. Merestinib (LY2801653) also inhibits MST1R, AXL, ROS1, MKNK1/2, FLT3, MERTK, DDR1 and DDR2 with IC50 of 11 nM, 2 nM, 23 nM, 7 nM, 7 nM, 10 nM, 0.1 nM and 7 nM, respectively.
NPJ Breast Cancer, 2024, 10(1):65
Cancers (Basel), 2024, 16(12)2253
J Clin Invest, 2021, 131(11)146987
E1825New 7rh 7rh (DDR1-IN-2) is a potent inhibitor of discoidin domain receptor 1 (DDR1) with an IC50 of 13.1 nM. It also inhibits DDR2 less effectively with an IC50 of 203 nM. It also exhibits antitumor effects in nasopharyngeal carcinoma cells.
E0621 FGFR1/DDR2 inhibitor 1 FGFR1/DDR2 inhibitor 1 is an inhibitor of fibroblast growth factor receptor 1 (FGFR1) and discoidin domain receptor 2 (DDR2).
S6817 VU6015929 VU6015929 is a selective Discoidin Domain Receptor 1/2 (DDR1/2) inhibitor with IC50 of 4.67 nM and 7.39 nM for DDR1 and DDR2, respectively. VU6015929 potently inhibits collagen-IV production.
F0725New DDR1 Rabbit mAb DDR1,NEP
E1825New 7rh 7rh (DDR1-IN-2) is a potent inhibitor of discoidin domain receptor 1 (DDR1) with an IC50 of 13.1 nM. It also inhibits DDR2 less effectively with an IC50 of 203 nM. It also exhibits antitumor effects in nasopharyngeal carcinoma cells.

Choose Selective DDR Inhibitors

Tags: DDR inhibitor|DDR agonist|DDR activator|DDR inducer|DDR antagonist|DDR signaling pathway|DDR assay kit